BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16909260)

  • 21. Self-assembly of SiO2/Gd-DTPA-polyethylenimine nanocomposites as magnetic resonance imaging probes.
    Luo K; Tian J; Liu G; Sun J; Xia C; Tang H; Lin L; Miao T; Zhao X; Gao F; Gong Q; Song B; Shuai X; Ai H; Gu Z
    J Nanosci Nanotechnol; 2010 Jan; 10(1):540-8. PubMed ID: 20352889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
    PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface modification of gadolinium oxide thin films and nanoparticles using poly(ethylene glycol)-phosphate.
    Guay-Bégin AA; Chevallier P; Faucher L; Turgeon S; Fortin MA
    Langmuir; 2012 Jan; 28(1):774-82. PubMed ID: 21970413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging.
    de Vries A; Moonen R; Yildirim M; Langereis S; Lamerichs R; Pikkemaat JA; Baroni S; Terreno E; Nicolay K; Strijkers GJ; Grüll H
    Contrast Media Mol Imaging; 2014; 9(1):83-91. PubMed ID: 24470297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of the relaxivity effects of iodine on GD-DTPA enhanced MR arthrography.
    Ganguly A; Gold GE; Butts Pauly K; Mayer D; Moseley MM; Pelc NJ; Fahrig R
    J Magn Reson Imaging; 2007 Jun; 25(6):1219-25. PubMed ID: 17520728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relaxivity of Gd-based contrast agents on X nuclei with long intrinsic relaxation times in aqueous solutions.
    van Heeswijk RB; Laus S; Morgenthaler FD; Gruetter R
    Magn Reson Imaging; 2007 Jul; 25(6):821-5. PubMed ID: 17448617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
    Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
    Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Block copolymer-based gadolinium nanoparticles as MRI contrast agents with high T1 relaxivity.
    Hou S; Tong S; Zhou J; Bao G
    Nanomedicine (Lond); 2012 Feb; 7(2):211-8. PubMed ID: 22339134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
    Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
    J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd₂O₃-DEG for molecular MRI.
    Zohdiaghdam R; Riyahi-Alam N; Moghimi HR; Haghgoo S; Alinaghi A; Azizian G; Ghanaati H; Gorji E; Rafiei B
    J Microencapsul; 2013; 30(7):613-23. PubMed ID: 23915304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced production of reactive oxygen species by gadolinium oxide nanoparticles under core-inner-shell excitation by proton or monochromatic X-ray irradiation: implication of the contribution from the interatomic de-excitation-mediated nanoradiator effect to dose enhancement.
    Seo SJ; Han SM; Cho JH; Hyodo K; Zaboronok A; You H; Peach K; Hill MA; Kim JK
    Radiat Environ Biophys; 2015 Nov; 54(4):423-31. PubMed ID: 26242374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis route and three different core-shell impacts on magnetic characterization of gadolinium oxide-based nanoparticles as new contrast agents for molecular magnetic resonance imaging.
    Azizian G; Riyahi-Alam N; Haghgoo S; Moghimi HR; Zohdiaghdam R; Rafiei B; Gorji E
    Nanoscale Res Lett; 2012 Oct; 7(1):549. PubMed ID: 23033866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
    Tofts PS; Shuter B; Pope JM
    Magn Reson Imaging; 1993; 11(1):125-33. PubMed ID: 8423715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.
    Zhang L; Liu Y; Yu D; Zhangl N
    J Biomed Nanotechnol; 2013 May; 9(5):863-9. PubMed ID: 23802417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
    Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
    Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.